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OBJECTIVES We sought to use echocardiography to assess the presentation and potential for recovery of
left ventricular (LV) function of patients with fulminant myocarditis compared with those
with acute myocarditis.
BACKGROUND The clinical course of patients with myocarditis remains poorly defined. We have previously
proposed a classification that provides prognostic information in myocarditis patients.
Fulminant myocarditis causes a distinct onset of illness and severe hemodynamic compromise,
whereas acute myocarditis has an indistinct presentation, less severe hemodynamic compro-
mise and a greater likelihood of progression to dilated cardiomyopathy.
METHODS Echocardiography was performed at presentation and at six months to test the hypothesis that
fulminant (n 5 11) or acute (n 5 43) myocarditis could be distinguished morphologically.
RESULTS Patients with both fulminant (fractional shortening 19 6 4%) and acute myocarditis (17 6
7%) had LV systolic dysfunction. Patients with fulminant myocarditis had near normal LV
diastolic dimensions (5.3 6 0.9 cm) but increased septal thickness (1.2 6 0.2 cm) at
presentation, while those with acute myocarditis had increased diastolic dimensions (6.1 6
0.8 cm, p , 0.01 vs. fulminant) but normal septal thickness (1.0 6 0.1 cm, p 5 0.01 vs.
fulminant). At six months, patients with fulminant myocarditis had dramatic improvement in
fractional shortening (30 6 8%) compared with no improvement in patients with acute
myocarditis (19 6 7%, p , 0.01 for interaction between time and type of myocarditis).
CONCLUSIONS Fulminant myocarditis is distinguishable from acute myocarditis by echocardiography.
Patients with fulminant myocarditis exhibit a substantial improvement in ventricular function
at six months compared with those with acute myocarditis. Echocardiography has value in
classifying patients with myocarditis and may provide prognostic information. (J Am Coll
Cardiol 2000;36:227–32) © 2000 by the American College of Cardiology
Myocarditis is an inflammatory disease of the myocardium
of uncertain etiology and may be a precursor of dilated
cardiomyopathy (DCM) (1,2). Although standardized his-
tologic criteria, the Dallas Criteria, have been widely applied
both clinically and in therapeutic trials (3), the optimal
prognostic classification system remains controversial (4).
Because both complete recovery of left ventricular (LV)
function and progression to DCM have been described, the
ability to assess prognosis at the time of presentation is
clearly of great benefit in patients with myocarditis (1,5,6).
We have previously proposed a clinicopathologic classi-
fication utilizing both histologic and clinical features that
may provide prognostic information in patients with myo-
carditis (7). Fulminant myocarditis is characterized by a
distinct viral prodrome, the sudden onset of severe hemo-
dynamic compromise and marked myocardial inflammation.
In contrast, patients with acute myocarditis have an indis-
tinct onset of symptoms, less severe hemodynamic embar-
rassment and a more variable degree of myocardial inflam-
mation. Recently, we have shown that patients with
fulminant myocarditis have improved long-term survival
compared with those with the acute form of the condition
(8). The purpose of this study was to use echocardiography
to assess the presentation of patients with fulminant myo-
carditis as compared with those with acute myocarditis. A
secondary aim of this study was to compare the potential for
recovery of LV function in patients with fulminant and
acute myocarditis.
METHODS
Study population. Seven hundred fifty patients underwent
endomyocardial biopsy at our institution over a seven-year
period as part of a comprehensive evaluation of unexplained
cardiomyopathy. Seventy-two of 750 patients (9.6%) were
diagnosed as having myocarditis or borderline myocarditis
by the Dallas Criteria (3). This group did not include
patients who had evidence of myocarditis in the setting of a
systemic process such as human immunodeficiency virus
infection or sarcoidosis. Patients were further classified as
having acute, fulminant, chronic active or chronic persistent
myocarditis, using our previously reported classification
system (7). Using these criteria, 43 patients were classified as
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having acute myocarditis and 11 as having fulminant myo-
carditis. These 54 patients were the subjects of this study.
Echocardiography. Standard two-dimensional echocardi-
ography was performed at the time of presentation and after
six months. Baseline echocardiograms for each patient were
evaluated. Follow-up echocardiograms at six months for
seven patients with fulminant myocarditis and 25 patients
with acute myocarditis were evaluated. Of the patients with
no follow-up echocardiograms available, two patients with
fulminant (18%) and four patients with acute myocarditis
(9%) died. Two patients with fulminant (18%) and 14 with
acute myocarditis (32%) were lost to follow-up. For each
echocardiogram, left ventricular diastolic dimension
(LVEDD) and maximal septal thickness were measured by
M-mode in the parasternal long axis view using the leading-
edge to leading-edge method. Percentage fractional short-
ening (%FS) was calculated in a standardized manner (9).
Endomyocardial biopsy. All patients underwent endo-
myocardial biopsy using a right internal jugular vein ap-
proach and a Stanford-Caves or disposable bioptome. At
least four specimens were taken from the right ventricular
septum and immediately placed in either 10% formalin for
light microscopy or 3% glutaraldehyde for electron micros-
copy. Each formalin-fixed specimen was stained with
hematoxylin-eosin and examined at at least four levels by an
experienced cardiac pathologist (R.H.H., G.M.H.). The
presence of myocarditis or borderline myocarditis was de-
termined according to the Dallas Criteria (3) and graded as
mild, moderate, or severe blinded to patient classification.
The diagnosis of myocarditis was confirmed by immuno-
histochemical staining for T-lymphocytes.
Hemodynamics. After endomyocardial biopsy, all patients
underwent right heart catheterization using a balloon-
tipped, flow-directed thermodilution catheter. Measure-
ments of cardiac output were obtained in triplicate with
,10% variability between measurements. Cardiac index,
LV stroke work index, systemic vascular resistance index
and pulmonary vascular resistance index were calculated
using standard formulas.
Statistical analysis. All values are reported as mean 6
standard deviation. Measurements between groups at base-
line were compared using the Student t test. Two-way
repeated measures analysis of variance was used for assessing
the interaction between type of myocarditis and changes at
baseline and six months, with time as the within patient
variable and type of myocarditis as the between patient
variable (Stata 6.0, College Station, Texas). A two-sided p
value , 0.05 was considered statistically significant.
RESULTS
Patient characteristics. The initial clinical characteristics
of the patients with fulminant and acute myocarditis are
shown in Table 1. By definition, the baseline characteristics
differed between the two groups. All patients with fulmi-
nant myocarditis reported a flu-like prodrome or fever in the
four weeks proceeding the onset of cardiac symptoms,
compared with 21% in the acute myocarditis group. Patients
with fulminant myocarditis generally had the abrupt onset
of symptoms within two weeks of presentation, whereas
symptom onset in those with acute myocarditis was indis-
tinct (dated to a period of weeks to months). All patients
classified as fulminant myocarditis had New York Heart
Association class III or IV heart failure symptoms, while
functional limitation in those with acute myocarditis was
more variable.
Echocardiography. Echocardiographic measurements at
baseline and at six months are shown in Figures 1 and 2.
Both groups had markedly decreased LV systolic function at
baseline that was of similar magnitude (%FS 5 17 6 7% for
acute vs. 19 6 4% for fulminant, p 5 NS, normal 28% to
41%). Patients with fulminant myocarditis had significantly
less ventricular dilation at baseline (LVEDD 5 5.3 6
0.9 cm vs. 6.1 6 0.8 cm, p , 0.01, normal , 5.5 cm) but
greater septal thickness (1.2 6 0.2 cm vs. 1.0 6 0.1 cm, p 5
0.01) than patients with acute myocarditis.
At six months, the patients with fulminant myocarditis
showed a marked improvement in the %FS (30 6 8%, p ,
0.01 vs. baseline), resulting in normal LV systolic function.
In contrast, patients with acute myocarditis showed no
significant improvement in fractional shortening at six
months compared with baseline (%FS 5 19 6 7%, p 5 NS
vs. baseline). The interaction between type of myocarditis
and time for fractional shortening was highly significant
(p , 0.01). Complete normalization of ventricular function
was significantly more likely in patients with fulminant
myocarditis (57%) than in those with acute myocarditis
(20%, p 5 0.05).
There was a trend towards greater resolution of septal
thickening in the fulminant group (from 1.2 6 0.2 cm at
baseline to 1.0 6 0.1 cm at six months) than the acute group
(1.0 6 0.1 cm at both baseline and six months), but this did
Abbreviations and Acronyms
DCM 5 dilated cardiomyopathy
LV 5 left ventricle or ventricular
LVEDD 5 left ventricular diastolic dimension
%FS 5 percentage fractional shortening
Table 1. Baseline Clinical Characteristics of Patients With





Flu-like illness within 4 weeks 100% (11) 21% (9)
Fever within 12 weeks 91% (10) 23% (10)
Acute onset of symptoms 100% (11) 56% (24)
NYHA Functional Class
4 73% (8) 58% (25)
3 27% (3) 26% (11)
2 0% (0) 16% (7)
1 0% (0) 0% (0)
NYHA 5 New York Heart Association.
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not reach statistical significance (p 5 0.095 for the type of
myocarditis/time interaction). Left ventricular diastolic di-
mension at six months remained significantly smaller in the
fulminant group than it did in the acute group (5.1 6
0.6 cm vs. 6.2 6 0.9 cm, p , 0.01). Left ventricular diastolic
dimension did not significantly changed in either group
between baseline and six months (p 5 0.63 for type of
myocarditis/time interaction).
Histology. The histologic characteristics of endomyocar-
dial biopsy specimens for study patients are shown in Table
2. All patients in the study had either histologic myocarditis
(81%) or borderline myocarditis (19%) on endomyocardial
biopsy as criteria for study entry. All patients in the
fulminant group had histologic myocarditis by the Dallas
Criteria. In the acute group, myocarditis was diagnosed in
77% of patients, with the remainder having borderline
myocarditis. By definition, the degree of inflammation seen
on endomyocardial biopsy specimens was substantially
greater in patients with fulminant myocarditis than those
with acute myocarditis (Fig. 3).
Hemodynamics. Hemodynamic measurements at the time
of endomyocardial biopsy for both groups are shown in
Table 2. Patients with fulminant myocarditis had more
severe hemodynamic compromise at presentation than those
with acute myocarditis. Mean arterial pressure and systemic
vascular resistance were both significantly decreased in the
fulminant group when compared with those with acute
myocarditis (p , 0.01 for each), despite substantially higher
use of intravenous inotropic agents in patients with fulmi-
nant myocarditis (64% vs. 5%). Heart rate, right atrial
pressure, pulmonary artery mean pressure and pulmonary
capillary wedge pressure were all significantly higher in the
fulminant myocarditis group than they were in the acute
group (p , 0.03 for each).
DISCUSSION
This study reports the echocardiographic findings of pa-
tients with two different clinical syndromes of myocarditis,
fulminant and acute. Patients with these two subtypes could
be distinguished by echocardiography. Patients with fulmi-
nant myocarditis presented with nondilated, thickened and
hypocontractile LVs, whereas those with acute myocarditis
had marked LV dilation, normal LV thickness and de-
creased LV function. At six-month follow-up, significant
improvement in %FS had occurred in the fulminant group,
whereas those with acute myocarditis showed no improve-
ment. Echocardiography may aid in classifying patients with
myocarditis into clinically relevant subgroups with prognos-
tic implications.
Prior studies of echocardiography in myocarditis. Previ-
ous studies of echocardiography in myocarditis have dem-
onstrated a variety of echocardiographic findings. In addi-
Figure 1. Echocardiographic findings in patients with fulminant and acute
myocarditis at baseline and six months. (A) Fractional shortening, (B) left
ventricular end-diastolic dimension, (C) septal thickness. *p , 0.01 vs.
acute; †p , 0.01 for interaction between time and type of myocarditis.
Table 2. Hemodynamics and Histologic Characteristics of








Myocarditis 100% (11) 77% (33) NS
Borderline myocarditis 0% (0) 23% (10)
Inflammation
Severe 55% (6) 5% (2) , 0.01
Moderate 45% (5) 14% (6)
Mild 0% (0) 81% (35)
Hemodynamics
Right atrial pressure 11 6 8 4 6 3 , 0.01
Mean pulmonary artery pressure 28 6 11 21 6 9 0.03
Pulmonary artery wedge pressure 21 6 11 14 6 9 0.03
Mean blood pressure 79 6 11 90 6 12 , 0.01
Heart rate (beats/min) 109 6 21 91 6 21 , 0.01
Cardiac index (L/min/m2) 2.8 6 0.9 2.5 6 0.6 NS
SVRI (dyneszseczcm25zm2) 2,072 6 440 2,939 6 752 , 0.01
PVRI (dyneszseczcm25zm2) 244 6 242 218 6 150 NS
LVSWI (g-m/m2) 21 6 11 31 6 14 NS
All pressures in mm Hg; all values given as mean 6 standard deviation.
NS 5 not significant; SVRI 5 systemic vascular resistance index; PVRI 5
pulmonary vascular resistance index; LVSWI 5 left ventricular stroke work index.
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tion to systolic dysfunction (10,11), regional wall motion
abnormalities (10), diastolic dysfunction (12) and changes in
echocardiographic image texture (13) have been reported.
These studies have not attempted to distinguish clinical
syndromes within the spectrum of patients with myocardi-
tis. Additionally, some reports have utilized clinical rather
than histologic criteria in making the diagnosis of myocar-
ditis, potentially confounding their results by including
patients who may not have had histologic evidence of
myocarditis. We have shown the utility of echocardiography
in classifying patients with histologically proven myocarditis
based on LV morphology at presentation.
Data from several previous studies are consistent with our
findings. Pinamonti and colleagues (10) described echocar-
diographic findings in 41 patients with histologically proven
myocarditis and found LV dysfunction in 69%, primarily
with little to no dilation of the LV cavity (10). They also
noted four patients in their series with transient “LV
hypertrophy” in the setting of myocarditis. In two of these
patients, ventricular thickening was associated with dra-
matic improvement in LV function. Transient “LV hyper-
trophy” associated with myocarditis has also been reported
by Hauser and coworkers (14) in a 28-year-old woman with
sudden onset of severe heart failure (14). Spontaneous
resolution of LV thickening in this patient was associated
with normalization of systolic function and clinical recovery.
It is likely that these cases represent examples of the
fulminant type of myocarditis as described in this report.
Although the degree of LV dilation is often related to the
severity and duration of heart failure, our data demonstrate
that severe systolic dysfunction may occur in the absence of
significant ventricular dilation in patients with fulminant
myocarditis. Left ventricular dysfunction without significant
cavity dilation has also been reported as a variant of
idiopathic DCM in patients without myocarditis, and both
progression to DCM and normalization of systolic function
have been reported (15).
Potential mechanisms. The increased LV thickness in
fulminant myocarditis is likely due to the greater inflamma-
tory response seen on endomyocardial biopsy in these
patients. Interstitial edema may contribute to both thick-
ened ventricular walls and decreased ventricular contractility
in this disorder. The contrast between LV morphology seen
on echocardiography in fulminant and acute myocarditis is
demonstrated in Figure 2, showing dramatically differing
echocardiographic findings between fulminant and acute
myocarditis. The explanation for the differences in the
presentation and natural history of these disorders is un-
known. These differences may be influenced either by the
virulence or inoculum of the causative viral agent or by host
factors such as genetic predisposition (16–18). It is possible
that a more vigorous immune response in patients with
fulminant myocarditis is responsible for both the more
severe initial presentation and the improved outcome at six
months.
Outcomes in myocarditis. Widely variable outcomes in
patients with myocarditis have been described. A long-term
follow-up study by Quigley and colleagues (6) confirmed
Figure 2. Two-dimensional echocardiograms from patients with fulminant and acute myocarditis at presentation. The top panels show the parasternal long
axis (A) and short axis (B) views of a 20-year-old man with fulminant myocarditis who presented after five days of a viral syndrome followed by acute
hemodynamic collapse. Note the severe ventricular thickening (septal thickness 2.1 cm) but small ventricular cavity size (LVEDD 2.5 cm). After
hemodynamic support with intravenous inotropic agents and a left ventricular assist device, this patient recovered near normal left ventricular function. The
bottom panels show parasternal long axis (C) and short axis (D) views from a 19-year-old man with acute myocarditis who presented with three weeks
of fatigue, fevers and the gradual onset of dyspnea on exertion. Note the decreased ventricular thickness (septal thickness 5 0.6 cm) and marked dilated
left ventricular cavity (LVEDD 5 6.9 cm). At six month follow-up, LVEDD had increased to 8.0 cm, and the patient was awaiting cardiac transplantation.
LVEDD 5 left ventricular diastolic dimension.
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the variable prognosis in patients with this disorder, with
some patients regaining normal ventricular function and
others progressing to DCM. This study did not find a
correlation between the degree of LV dysfunction at pre-
sentation and subsequent echocardiographic or clinical out-
come. Similar findings were reported by Dec and coworkers
(1), who described 18 patients with acute onset of cardio-
myopathy and histologic myocarditis, of whom some made
complete recovery while others progressed to DCM. Nota-
bly, the two patients in this study with endomyocardial
biopsies demonstrating a “diffuse, dense inflammatory infil-
trate” on histologic examination both recovered LV func-
tion, whereas patients with a focal pattern of myocarditis
had a prognosis similar to patients with idiopathic DCM.
These data are in agreement with our findings, in which
patients with a more severe inflammatory infiltrate (i.e.,
those with fulminant myocarditis) had a much greater
propensity for recovery of normal ventricular function.
Echocardiographic criteria that predict outcome in patients
with myocarditis have not been well-established. Mendes
and colleagues (19) reported 23 patients with biopsy proven
myocarditis in whom the presence of right ventricular
dysfunction by echocardiography predicted worse clinical
outcome. We have examined the differences in echocardio-
graphic features between patients with differing clinical
syndromes and myocarditis and found substantial morpho-
logic differences at presentation that may predict subsequent
recovery of ventricular function.
Study limitations. This study has several potential limita-
tions. The number of patients was relatively small, particu-
larly in the group with fulminant myocarditis. Echocardio-
graphic follow-up was incomplete in both the acute and
Figure 3. Endomyocardial biopsy specimens from patients with fulminant (A) and acute (B) myocarditis. Fulminant myocarditis was characterized by more
extensive and diffuse lympocytic infiltration and myocyte necrosis than acute myocarditis (hematoxylin-eosin stain, original magnification 3 400).
231JACC Vol. 36, No. 1, 2000 Felker et al.
July 2000:227–32 Echocardiography in Myocarditis
fulminant myocarditis groups, reducing the power of our
conclusions regarding the changes in morphology between
baseline and six months. Still, this study represents the
largest systematic study of echocardiographic findings in
patients with biopsy proven myocarditis. Our study was
retrospective, but the classification into categories of myo-
carditis was done prospectively. All diagnoses of myocarditis
were based on accepted histologic criteria. Although inflam-
matory cell infiltrates have been demonstrated in some cases
of idiopathic DCM (20), 81% of our cases showed frank
myocarditis, and we used immunohistochemical staining for
T-lymphocytes to confirm the diagnosis in all cases of
borderline myocarditis.
The use of immunosuppression was not controlled in this
study. Two of 11 patients with fulminant myocarditis and
30 of 43 patients with acute myocarditis received some type
of immunosuppressive therapy, generally corticosteroids.
While it is possible that the greater use of immunosuppres-
sive therapy in the patients with acute myocarditis may have
led to worse echocardiographic outcomes in this group, this
does not seem to be a plausible explanation for our findings.
Our previous experience has suggested that patients with
fulminant myocarditis, despite their severe clinical presen-
tation, improve without immunosuppression. The utility of
immunosuppression in acute myocarditis is unclear, but a
consistent benefit was not seen in the Myocarditis Treat-
ment Trial (21). Given the observational methods used in
this study, no conclusions can be drawn regarding the utility
of immunosuppression in either group.
Treatment implications. Our data suggest that the pres-
ence of septal thickening and normal LV dimensions in a
patient with a fulminant presentation and severe hemody-
namic compromise portends a high likelihood of ventricular
recovery. Maximal medical support, including intravenous
inotropic agents and placement of a temporary LV assist
device, should be considered for these patients in order to
provide time for potential recovery of LV function, as has
been described in case reports (22,23). Given the high
likelihood of ventricular recovery, early consideration of
cardiac transplantation may be avoided in patients with
fulminant myocarditis.
Conclusions. This study suggests that patients with fulmi-
nant myocarditis have an echocardiographic presentation that
is distinct from that of patients with acute myocarditis. Addi-
tionally, patients with fulminant myocarditis are significantly
more likely to recover LV function than are those with acute
myocarditis. Echocardiography provides important prognostic
information and may aid in the clinically relevant classification
of patients with histologically proven myocarditis.
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